Cel-sci reports fiscal 2022 financial results and clinical & corporate developments

Vienna, va.--( business wire )--cel-sci corporation (nyse american: cvm) reported financial results for the fiscal year ended september 30, 2022, as well as key clinical and corporate developments.
CVM Ratings Summary
CVM Quant Ranking